Therapy Areas: Hereditary Disorders
2 September 2022 - - The US Food and Drug Administration approved expanded use of Orkambi (lumacaftor/ivacaftor) to include children with cystic fibrosis ages 12 to ...
19 August 2022 - - US-based clinical messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has released updated data from its ongoing ARCT-154 booster clinical trial.
15 August 2022 - - Australia-based epigenetics company EpiAxis Therapeutics and US-based biotech company Peptilogics ave entered a collaboration to leverage AI for drug discovery to inhibit epigenetic...
1 August 2022 - - US-based biotechnology company Vicinitas Therapeutics has launched with USD 65m in series A financing, the company said.

The financing was co-led by a16z and Deerfield M...
18 July 2022 - Ireland-based Endo International plc (NASDAQ: ENDP) announced on Friday that its subsidiary Endo Ventures Limited has signed contract with Quoin Pharmaceuticals Inc. (NASDAQ: QNRX), an ...
7 July 2022 - - US-based genetic medicines company ReCode Therapeutics has closed a series B extension financing round, co-led by new investors, Leaps by Bayer, the impact investment unit of Bayer AG,...
Related Headlines